The main aim of this study is to learn if fazirsiran is safe during long-term use in people with liver disease caused by the abnormal Z-alpha-1 antitrypsin (Z-AAT) protein. People who have taken part in previous fazirsiran studies (AROAAT2001鈥�
- Investigator
- Ginger Clark
- Ages
- 18 Years - N/A
- Sexes
- All